ctrl K

Price Alert

Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

11.36

0.03 (0.26%)

At close: Aug 18, 2025, 3:59 PM

11.28

-0.70%

After-hours: Aug 18, 2025, 04:10 PM EDT

Cartesian Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	212.61M	76.91M	106.44M	114.06M
Short-Term Investments	n/a	n/a	28.16M	14M
Long-Term Investments	2M	2M	2M	2M
Other Long-Term Assets	2.19M	1.38M	1.34M	1.47M
Receivables	872K	8.85M	9.86M	9.91M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	3.14M	4.97M	3.39M	n/a
Total Current Assets	216.63M	90.73M	148.14M	144.44M
Property-Plant & Equipment	15.45M	12.18M	14.41M	11.97M
Goodwill & Intangibles	198.76M	198.76M	n/a	n/a
Total Long-Term Assets	218.4M	214.32M	17.75M	15.44M
Total Assets	435.02M	305.05M	165.89M	159.88M
Account Payables	288K	3.15M	316K	224K
Deferred Revenue	n/a	2.31M	593K	53.88M
Short-Term Debt	2.85M	n/a	8.48M	5.96M
Other Current Liabilities	19.84M	56.19M	19.68M	14.71M
Total Current Liabilities	22.98M	68.21M	25.08M	72.25M
Long-Term Debt	n/a	-322.08M	17.79M	19.67M
Other Long-Term Liabilities	391.57M	342.62M	19.14M	25.42M
Total Long-Term Liabilities	418.85M	677.02M	46.98M	65.11M
Total Liabilities	441.82M	745.23M	72.06M	137.36M
Total Debt	13.98M	10.96M	37.92M	35.28M
Common Stock	3K	16K	15K	12K
Retained Earnings	-692.07M	-614.65M	-394.94M	-430.32M
Comprehensive Income	-4.62M	-4.6M	-4.56M	-4.57M
Shareholders Equity	-6.8M	-440.18M	93.83M	22.52M
Total Investments	2M	2M	30.16M	16M